Executive Roundtable

Leadership During Pandemic

July 01, 2020

Pharmaceutical Executive

A recent roundtable moderated by Dr. Scott Gottlieb gathered biopharma CEOs to share thoughts and strategies on navigating their companies through the COVID-19 outbreak.

Compliance Disruptors

July 15, 2019

Pharmaceutical Executive

Big pharma compliance leaders discuss the strategic move to principles-based policies at their companies and the impact of other emerging forces influencing industry compliance practice, including data analytics and security and training approaches adaptable to new workplace dynamics.

Science & Finance: The Biotech Blend

January 30, 2019

Pharmaceutical Executive

Financial leaders from clinical-stage biopharma gather to discuss the critical role of finance and accounting (F&A) in supporting and sustaining the science at the forefront of engagement with investors.

Paul Perreault: The Global CEO

September 21, 2018

Pharmaceutical Executive

Pharm Exec talks with CSL Limited’s top executive about the realities of running the global, Australian-headquartered specialty biotech company and sustaining a strong focus in a fast-encroaching era of disruptive technologies and new priorities in innovation and R&D.

Compliance: The Critical Cog in Pharma Machine

July 10, 2018

Pharmaceutical Executive

Pharm Exec convenes an expert panel at CBI’s Pharmaceutical Compliance Congress to discuss new ways to navigate the many complexities when it comes to the crucial task of assessing business and risk in the life sciences.

Pharma: Meet Your New Neighbors

March 20, 2018

Pharmaceutical Executive

Executives from diagnostics, payer, pharma, and patient care companies converge to share the inside scoop on outcomes-based contracting.

Epidemiology Arising: A Pharm Exec Roundtable

August 11, 2015

Pharmaceutical Executive

Experts from industry and academia probe the changing role of the pharmacoepidemiology function as it grapples with the challenges of big data analytics, tightening drug safety requirements, growing post-approval study burdens, and payer expectations around the application of real-world evidence.

Building Tomorrow’s Biopharma Workforce

July 16, 2015

Pharmaceutical Executive

In a knowledge industry like biopharma, people are the intangible asset that marks the difference between a status quo or standout performance. Pharm Exec recently convened a panel of industry team leaders and HR specialists at St. Joseph’s University Haub School of Business to parse out some useful best practices in three key areas: talent recruitment and retention; skills training; and workforce diversity.

Hard Science, High Hopes: Dealmakers' Roundtable

June 10, 2015

Pharmaceutical Executive

Masters of the deal converge in New York to discuss the status of their trade and the forces propelling M&A, licensing, and partnerships in the life sciences for 2015.